Abatacept is used to treat autoimmune diseases like rheumatoid arthritis. It works by inhibiting T-cell activation, reducing immune response. It is grouped under the following drug class(es): Biologics and Immunosuppressants. Its therapeutic use is listed as anti-inflammatories and antirheumatic agents. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include CTLA4-Ig Immunoconjugate, abataceptum and CTLA4-IgG4m. Its PubChem SID is 481101466.
Abatacept
| CAS No | 332348-12-6 |
|---|---|
| Molecular Formula | C3498H5458N922O1090S32 |
| Molecular Weight | ~92 kDa |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Abatacept is used to treat autoimmune diseases like rheumatoid arthritis. It works by inhibiting T-cell activation, reducing immune response. It is grouped under the following drug class(es): Biologics and Immunosuppressants.
The listed CAS number is 332348-12-6.
The listed molecular formula is C3498H5458N922O1090S32.
The listed molecular weight is ~92 kDa.
N/A.
The source lists CTLA4-Ig Immunoconjugate, abataceptum and CTLA4-IgG4m.